Gina D. Schellenbaum
Journal of the American Medical Association (JAMA) · 2003
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Gina D. Schellenbaum trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Thomas Lumley (in Statistics and Probability)
Papers from Gina D. Schellenbaum's perspective
Ordered by how strongly the researchers Gina D. Schellenbaum trusts endorse each paper. Same corpus, a different order for every researcher.
- Network meta‐analysis for indirect treatment comparisons (Statistics in Medicine)
- Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. (Journal of the American Medical Association (JAMA))
- Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses (British medical journal)
- Measuring inconsistency in meta-analyses (British medical journal)
- Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. (American Journal of Kidney Diseases)
- Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research,… (HYPERTENSION)
- RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis (Bioinform.)
- Nonparametric Estimation from Incomplete Observations
- Controlling the risk of spurious findings from meta‐regression (Statistics in Medicine)